Transplantation and Cellular Therapy
Издатель: Elsevier · ISSN 2666-6367 · 97 статей
- Clinical Trials in Graft-Versus-Host Disease: Changes in Study Characteristics, Investigated Drugs, and Endpoints Over Time
- Prospective Validation of Multiweek Inpatient Census Forecasting for Pediatric HSCT and Cellular Therapy
- Autologous Stem Cell Transplantation, Chimeric Antigen Receptor T Cell Therapy, or Combined Consolidation for Relapsed/Refractive Primary Central Nervous System Lymphoma in Reachieved Complete Remission: An Inverse Probability of Treatment Weighting-Adjusted Comparative Study
- Exercise Duration during a Brief Step Test Independently Predicts Outcomes after Hematopoietic Cell Transplantation
- The Effect of Belumosudil on the Therapeutic Drug Levels of Tacrolimus and Sirolimus in Allogeneic Hematopoietic Transplantation
- Comment on “Tooth Loss and Oral Health-Related Quality of Life in a Subcohort within the Chronic Graft-versus-Host Disease Consortium”
- Comment on “Alemtuzumab, Fludarabine, Melphalan, and Thiotepa Conditioning for Transplantation in Inborn Errors of Immunity”
- Rethinking Letermovir Strategy Beyond Day +100 for Late CMV Prevention After Allogeneic Hematopoietic Cell Transplantation
- Comment on “Immune Reconstitution After Allogeneic Stem Cell Transplantation: Time Alone Does Not Heal All Wounds”
- An Open-label, Multicenter, Phase 2 Study to Assess the Safety and Efficacy of Burixafor (GPC-100) in Combination with Propranolol and G-CSF for the Mobilization of Hematopoietic Progenitor Cells in Multiple Myeloma Patients
- Association between anti-thymocyte globulin exposure and clinical outcomes of adult undergoing haploidentical hematopoietic stem cell transplantation with myeloablative conditioning: a pharmacokinetic-guided study
- SEXUAL FUNCTION IN WOMEN UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION: RESULTS OF AN OBSERVATIONAL STUDY
- Impact of Venetoclax Bridging on Haematopoietic Stem Cell Transplantation Outcomes in Advanced Myelodysplastic Neoplasms
- Five-Year Follow-Up of ZUMA-3: A Phase 1/2 Study of Brexucabtagene Autoleucel for the Treatment of Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
- Infusion timing and outcomes after allogeneic hematopoietic cell transplantation across graft sources
- Risk-Adapted Donor Selection in Patients with Acute Myeloid Leukemia
- Daratumumab, Bortezomib, Lenalidomide and Dexamethasone, Upfront Autologous Transplant and Lenalidomide Maintenance for Newly Diagnosed Multiple Myeloma
- Post-transplant cyclophosphamide and single-agent tacrolimus as GvHD prophylaxis for allogeneic peripheral blood stem cell transplantation. Comparison between haploidentical and HLA matched/single-allele mismatched donors and impact of lower doses of PTCy
- Sepsis in Chimeric Antigen Receptor T-Cell Therapy: A Six-Year Nationwide Analysis of Clinical Outcomes and Healthcare Resource Utilization in Hospitalizations for Hematologic Malignancies
- Early T-cell Large Granular Lymphocyte Expansions in Patients with Cytopenias after CD19 CAR T-cell Therapy
- Reply to “Does Lower PTCy Dose Increase GVHD?”
- Association of Post-Transplant Cyclophosphamide Dose with BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Cell Transplantation
- Traversing the Last Mile: Bringing Chimeric Antigen Receptor T-Cell Therapy to the Community Setting
- Thiotepa/Busulfan/Cyclophosphamide versus Busulfan/Thiotepa Conditioning For Autologous Stem Cell Transplantation in CNS Lymphoma: A Single-Center Comparative and Descriptive Experience
- Allogeneic CD33/CD123 CAR-T сells in pediatric relapsed/refractory AML: early single-center experience
- The effect of coping strategies on overall survival and other outcomes after allogeneic stem cell transplant
- Caregiver Stress and Coping during Pediatric Hematopoietic Stem Cell Transplant: Perspectives of Caregivers and Healthcare Providers
- Ligand/receptor-based chimeric antigen receptors: a promising alternative to conventional scFv designs in cancer immunotherapy
- Bone marrow niche disruption via interferon gamma-mediated CXCL9/CXCL10 secretion after allogeneic transplantation
- Attrition Factors in Patients with Metastatic Melanoma Screened for Tumor Infiltrating Lymphocyte Therapy